What will the discount to 5 day VWAP be for the share placement, and who is the investor?, page-225

Okay back to some serious discussion, enough with the trolls and BS- I am not a racist- I hate everyone equally - LMAO -HAHHAHAHAHAH

So I actually approached one of the cardio professors at the hospital- I really had to muster a lot of courage to go speak to him- him being such an intellectual and so clevor. I asked him about Mesoblast and he knows them well, he said that Mesoblast are actually going to have discussions to approve their CHF treatment based on the fact they its reducing inflammation in the heart, I think he said it protects the tissue of the heart, but most importantly it reduces mortality, this I found very interesting that I FDA will look at the benefits and he said something about the markers being positive as opposed to the primary endpoints.